Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adipose Stromal Cells for Revascularization in CAD
NCT04005989Phase 3Withdrawn
- Sponsor
- HCor
- Start
- Dec 2021
- Primary completion
- Nov 2022
- Modality
- Stem Cell Therapies
01
Overview
A Phase 3 trial of adipose derived mesenchymal stromal cells in coronary artery disease (CAD), sponsored by HCor. Planned start Dec 2021; status: withdrawn.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04005989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04005989.